Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Evaluation of Docetaxel vs. Tamoxifen in Combined Therapies Based on Overall Survival Rate (OSR) Endpoint among Female Breast Cancer Patients
Adv Cancer Prev 2: 122. 2:1, (2017)
https://doi.org/10.4172/2472-0429.1000122